Answers are grounded in this paper and cite their sources.
Introduction Low-grade gliomas (LGGs) in infants pose significant clinical challenges due to their biologically distinct behavior and frequent location in surgically complex regions. While resection remains the preferred initial treatment, its feasibility is frequently limited by age-specific clinical and tumor-related factors. This review explores the role of tumor resection in infants and its association with survival, disease progression, and neurological outcome. Methods A systematic literature search identified studies published within the last decade reporting surgical outcomes in infants with LGGs. Retrospective and prospective cohort studies and relevant case reports were included. Methodological quality was assessed, and relevant data were extracted and analyzed. Results Complete resection was less commonly achieved in infants (20.1% vs. 30.9% in total), who demonstrate higher rates of tumor progression and more frequently require multimodal treatment strategies. Resectability was influenced by tumor location, growth pattern, and patient age. Although infants appear to experience lower overall survival rates and greater need for adjuvant, non-surgical therapies, a greater extent of resection is consistently associated with improved survival outcomes, reduced rates of reoperation, and decreased reliance on additional therapeutic modalities. Conclusion In infants with LGG, the maximal safe extent of resection should be pursued where anatomically feasible. However, particularly for midline tumors, where extensive resection is often not possible, comprehensive assessment of tumor biology and further investigation of non-surgical treatment options are essential to optimize therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Dzionsko et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: